AGEN2373,Botensilimab
agenus
['solid tumor', 'agenus', '$agen']
exciting day at #asco23. we enjoyed discussing data from our phase 1 study of agen2373, a novel cd137 agonist antibody designed to avoid hepatoxicity, in #patients with advanced solid tumors. you can view the presentation at 
Advancing IO therapies and combinations to promote innovative and life-changing treatment options for cancer patients.